Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 36 most recent Form 4 transactions.
| Nuvalent, Inc. |
| DTOISS◆ |
| 3,789 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 3,789 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 43,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 43,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 2.7M | $124.00 | $337M | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS◆ | 2.7M | $124.00 | $337M | — | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 3,444 | $124.00 | $427.1K | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | UTENDR | 5,146 | $124.00 | $638.1K | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | UTENDR | 5,146 | $124.00 | $638.1K | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 650,000 | $124.00 | $80.6M | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 8.3M | $124.00 | $1B | -100.0% | Open the original filing on SEC.gov |
| Jul 15 | NUVL | Nuvalent, Inc. | DTOISS | 8.3M | $124.00 | $1B | -100.0% | Open the original filing on SEC.gov |
| Jun 16 | NUVL | Nuvalent, Inc. | AGRANT | 3,444 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 464,550 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 464,550 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 246,732 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 246,732 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 143,650 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 143,650 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 166,070 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV◆ | 166,070 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 407,132 | — | — | +76.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 407,132 | — | — | +76.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 260,992 | — | — | +95.9% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 260,992 | — | — | +95.9% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 149,238 | — | — | +121.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 149,238 | — | — | +121.3% | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 122,990 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | PBLS | Parabilis Medicines, Inc. | CCONV | 122,990 | — | — | — | Open the original filing on SEC.gov |
| May 19 | LRMR | Larimar Therapeutics, Inc. | AGRANT◆ | 55,150 | — | — | — | Open the original filing on SEC.gov |